{"name":"Spectral AI","slug":"spectral-ai","ticker":"MDAI","exchange":"NASDAQ","domain":"spectral-ai.com","description":"Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed decision regarding the treatment of the patient's wounds. Its system also develops AI-Burn software and MSI imaging technology, which consists of proprietary multi-spectral optics and sensors that capture injured tissue images. Spectral AI, Inc. is headquartered in Dallas, Texas.","hq":"Dallas, TX","founded":0,"employees":"65","ceo":"Peter Carswell","sector":"AI Diagnostics / Medical Devices","stockPrice":2.17,"stockChange":0.13,"stockChangePercent":6.37,"marketCap":"$69M","metrics":{"revenue":19650000,"revenueGrowth":-40.5,"grossMargin":46,"rdSpend":15100000,"netIncome":-7571000,"cash":11655000,"dividendYield":0,"peRatio":-2.3,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"SpectraVue patent cliff ($100M at risk)","drug":"SpectraVue","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-15","type":"regulatory","headline":"Spectral AI Receives FDA Clearance for AI-Powered Diagnostic Device","summary":"Spectral AI announced that it has received FDA clearance for its AI-powered diagnostic device, marking a significant milestone in the company's growth.","drugName":"","sentiment":"positive"},{"date":"2023-11-01","type":"earnings","headline":"Spectral AI Reports Strong Q3 Earnings, Beats Expectations","summary":"Spectral AI reported strong Q3 earnings, beating analyst expectations and demonstrating the company's continued growth and momentum.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxPZUtQcmhYSVRreVdXLTVSNWlBd2JXOUd6NVBwWEI5MHQ4aUU4YmFVTUpNa2pyQXJOOFZqQkVXX09KR0o5ekNQaUl5bkVFQ3MzUG1JUFl2c183RWpITFpZaFJVbmplbjZiS3c4d1RLek5nQU0wb2tXSm5fakpfcVBsdEoxQ09tb2cyOEpWaEVPXzNmNDhIaG1yeHZvUlBseXlJRG84RnJURjhKcHZlNEstd21iMzBZR0ZsSndEWE5KVGEtOUhKdDA5SGNSdzYxa1hTOG9UXzFTb003SmYzc1g1cGY5VFdaVXlZMWZLM1hWTWNPenBCS0VuRGhxMFU?oc=5","date":"2026-03-26","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT) - The Globe and Mail","headline":"Analysts Are Bullish on Top Healthcare Stocks: NRX Pharmaceuticals (NRXP), Rezolute (RZLT)","sentiment":"neutral"},{"date":"2026-03-25","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-03-25","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: ANNUAL REPORT","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"date":"2026-03-20","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxOblhRQlFGazlpTmRic1BFdDRHN1h1OWVDbWh4SWxSSlZBVHJSVWNkUGlQMEZrbGwwWTJSbDVuUVFvZERIeWpWYy1DOFJ2Wnp3X2hKSmlKeTM5VlJZMEJmNlZ2b0hPYndocGU5OVhPUzIyVkVMb3prVGVzUl9LNTNSZXhkRGNoQWNPZ2pfeXEtT0tvUHNMXzNfNFFHaThnNVU3ckFPYWloVDJPX05seFJ5ZU9DTFRXUQ?oc=5","date":"2026-03-03","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Adial Pharmaceuticals (NASDAQ:ADIL), Ensys - Benzinga","headline":"12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Adial Pharmaceuticals (NASDAQ:ADIL), Ensys","sentiment":"neutral"},{"date":"2026-02-10","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-02-03","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2026-01-06","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-11-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"date":"2025-10-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-08-13","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: CURRENT REPORT","headline":"SEC 8-K: CURRENT REPORT","sentiment":"neutral"},{"date":"2025-08-13","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: QUARTERLY REPORT","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPbFVzN2VEQjJpVmgzb0puYWVLRnhMcXF3VnhtcFdlX2Y4czhIYV9xVG16UEY4bVdNZVJkSFFzSW9fRG9aX2cwWThHbW50TXREYkJlY21LXzdhR3BmV2VETXZXaV82WlNfTG1BeGtlNWJFYkUwOWcxOGxQM25LMFJXS3NaOVpOckJIRG50MkZsM0oyN05WSDQzdDRmTWNOX3lZUmlJLUVKcnVVQ1dpRzNRVk9iMTVDREU?oc=5","date":"2024-10-15","type":"pipeline","source":"proactiveinvestors.com","summary":"Spectral AI founder returns as board chairman - proactiveinvestors.com","headline":"Spectral AI founder returns as board chairman","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxONXQtTVFJZXduLVE1eTVBbjNXMzFCQ3I5WlB4cWozLXdKajByX2FTTUlIYnUxTXQ2VHJucWY4ZVdrS1JaVDkzT3plNjhkTEhPLXNCM2RXQVZ3bm9WTkpUWUVMam9YRVkxNXJFNXpSZkhvQTdFTzM1elRBY1cwZHVsMEduYjhuX0JGU3ZnSUs2cVBJRWVWX0swRTl5eTJCalFfb3ByY0l3S1ZLVHZ2LUxqYnFhLU5uNzRUUjVMNkxZUHBKYmlh?oc=5","date":"2024-07-15","type":"pipeline","source":"proactiveinvestors.com","summary":"Spectral AI highlights concerns over stock manipulation - proactiveinvestors.com","headline":"Spectral AI highlights concerns over stock manipulation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQZ29IZUtCR0UzZm9QdFdTYmV1akY1bXl3QnY5dGpFemVDeHhfN2U1RGd3cFFOTXVCb0pUaDhWVUwwZUFwQk9tOExDUGlZQW9yZThxeDV0NTlyQ2hOLU5DSTdTN0MycWpYRWZ4QmY5UVBSX1dWNjdzRlEweEktd1QxaGQwLUFwTHRyV1VKMElpOW05SGYxc2VlekJsakYwMGg1T3p1MWF0eFBNS2NObkdhMlMzTERBQlJYcktEVWpLMkJXLXNsU284MVJSQzk3QzRrSkhZYkE1a1oxRk9z?oc=5","date":"2024-05-08","type":"regulatory","source":"proactiveinvestors.com","summary":"Spectral AI hails progress towards first sales and pre-FDA clinical trial - proactiveinvestors.com","headline":"Spectral AI hails progress towards first sales and pre-FDA clinical trial","sentiment":"neutral"}],"patents":[{"drugName":"SpectraVue","drugSlug":"spectravue","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":100000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["IBM Watson Health","Google Health","Microsoft Health Bot"],"therapeuticFocus":["Cancer Diagnostics","Cardiovascular Disease"],"financials":{"source":"sec_edgar+yahoo","revenue":19650000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":19650000,"period":"2025-12-31"},{"value":29581000,"period":"2024-12-31"},{"value":29581000,"period":"2024-12-31"},{"value":18056000,"period":"2023-12-31"},{"value":18056000,"period":"2023-12-31"}],"grossProfit":8925000,"grossProfitHistory":[{"period":"2025-12-31","value":8925000},{"period":"2024-12-31","value":13274000},{"period":"2023-12-31","value":7880000},{"period":"2022-12-31","value":10837000}],"rdSpend":15100000,"rdSpendHistory":[],"sgaSpend":17528000,"operatingIncome":-8603000,"operatingIncomeHistory":[{"period":"2025-12-31","value":-8603000},{"period":"2024-12-31","value":-6582000},{"period":"2023-12-31","value":-12984000},{"period":"2022-12-31","value":-2647000}],"netIncome":-7571000,"netIncomeHistory":[{"period":"2025-12-31","value":-7571000},{"period":"2024-12-31","value":-15158000},{"period":"2023-12-31","value":-20854000},{"period":"2022-12-31","value":-2912000}],"eps":-0.29,"epsHistory":[{"period":"2025-12-31","value":-0.29},{"period":"2024-12-31","value":-0.85},{"period":"2023-12-31","value":-1.48},{"period":"2022-12-31","value":-0.185616}],"cash":15394000,"cashHistory":[{"period":"2025-12-31","value":15394000},{"period":"2024-12-31","value":5157000},{"period":"2023-12-31","value":4790000},{"period":"2022-12-31","value":14174000}],"totalAssets":21405000,"totalLiabilities":27132000,"totalDebt":10094000,"equity":-5727000,"operatingCashflow":-9920000,"operatingCashflowHistory":[{"period":"2025-12-31","value":-9920000},{"period":"2024-12-31","value":-9199000},{"period":"2023-12-31","value":-13240000},{"period":"2022-12-31","value":-1162000}],"capex":-7000,"capexHistory":[{"period":"2021-12-31","value":-7000}],"freeCashflow":-9920000,"dividendsPaid":null,"buybacks":null,"employees":65,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":4089000,"ebit":1935000,"ebitda":2107000,"period":"2025-12-31","revenue":4086000,"epsBasic":0.02,"netIncome":1052000,"rdExpense":null,"epsDiluted":0.02,"grossProfit":1846000,"operatingIncome":-2243000},{"sga":4962000,"ebit":-3086000,"ebitda":-2915000,"period":"2025-09-30","revenue":3792000,"epsBasic":-0.13,"netIncome":-3552000,"rdExpense":null,"epsDiluted":-0.13,"grossProfit":1621000,"operatingIncome":-3341000},{"sga":4413000,"ebit":-2123000,"ebitda":-1974000,"period":"2025-06-30","revenue":5065000,"epsBasic":-0.31,"netIncome":-7968000,"rdExpense":null,"epsDiluted":-0.31,"grossProfit":2290000,"operatingIncome":-2123000},{"sga":4064000,"ebit":-896000,"ebitda":-753000,"period":"2025-03-31","revenue":6707000,"epsBasic":0.13,"netIncome":2897000,"rdExpense":null,"epsDiluted":0.11,"grossProfit":3168000,"operatingIncome":-896000},{"sga":4459000,"ebit":-6608000,"ebitda":-6475000,"period":"2024-12-31","revenue":7604000,"epsBasic":-0.41,"netIncome":-7742000,"rdExpense":null,"epsDiluted":-0.41,"grossProfit":3348000,"operatingIncome":-1111000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":2.17,"previousClose":2.04,"fiftyTwoWeekHigh":3.21,"fiftyTwoWeekLow":1.18,"fiftyTwoWeekRange":"1.18 - 3.21","fiftyDayAverage":1.73,"twoHundredDayAverage":1.83,"beta":0,"enterpriseValue":63203744,"forwardPE":-2.3,"priceToBook":-11.6,"priceToSales":4.08,"enterpriseToRevenue":3.73,"enterpriseToEbitda":-6.6,"pegRatio":0,"ebitda":-9579000,"ebitdaMargin":-56.6,"freeCashflow":-680625,"operatingCashflow":-12143000,"totalDebt":9938000,"debtToEquity":0,"currentRatio":0.75,"returnOnAssets":-31.5,"returnOnEquity":0,"analystRating":"","recommendationKey":"none","numberOfAnalysts":3,"targetMeanPrice":4.67,"targetHighPrice":6,"targetLowPrice":3,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":12.5,"institutionHeldPercent":15.5,"sharesOutstanding":31823985,"floatShares":27977341,"sharesShort":1987428,"shortRatio":4.59,"shortPercentOfFloat":6.2,"epsTrailing":-0.53,"epsForward":-0.94,"revenuePerShare":0.59,"bookValue":-0.19,"officers":[{"age":69,"name":"Dr. John Michael DiMaio M.D.","title":"Founder & Chairman"},{"age":58,"name":"Mr. Vincent Stanley Capone Esq.","title":"CEO & Corporate Secretary"},{"age":63,"name":"Mr. Stanley  Micek","title":"Chief Operating Officer"},{"age":47,"name":"Ms. Allison  Kumar","title":"Head of Regulatory Affairs & Clinical Trials"},{"age":65,"name":"Mr. Louis  Percoco","title":"General Manager"},{"age":55,"name":"Mr. Wensheng  Fan","title":"Co-Founder, Chief Innovation Strategist & Senior Advisor to the CEO"},{"age":46,"name":"Mr. David  McGuire","title":"Chief Financial Officer"}],"industry":"Medical Devices","irWebsite":"","website":"https://www.spectral-ai.com","phone":"972 499 4934"}}